Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study-Reference-Cited by-同舟云学术

Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study

Published:2017-10-25 Issue:7 Volume:66 Page:1013-1018
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

de Lédinghen Victor¹²,Laforest Claire³,Hézode Christophe⁴,Pol Stanislas⁵,Renault Alain³⁶,Alric Laurent⁷,Larrey Dominique⁸,Métivier Sophie⁹,Tran Albert¹⁰,Jézéquel Caroline¹¹,Samuel Didier¹²,Zoulim Fabien¹³,Tual Christelle³,Pailhé Aurélie¹⁴,Gibowski Séverine¹⁴,Bourlière Marc¹⁵,Bellissant Eric³⁶,Pawlotsky Jean-Michel¹⁶

Affiliation:

1. Hepatology Unit, University Hospital, CHU Bordeaux, Pessac

2. INSERM, Université Bordeaux, UMR1053 Bordeaux Research in Translational Oncology, BaRITOn

3. CHU Rennes, Service Pharmacologie, and INSERM, CIC 1414

4. Service d’Hépatologie, CHU Henri-Mondor, AP-HP, Université Paris-Est, INSERM U955, Créteil

5. Université Paris Descartes, Hepatology Department, Cochin Hospital, APHP, INSERM U1223, UMS-20 and Center for Translational Science, Institut Pasteur

6. Université Rennes 1, Faculté de médecine, laboratoire de pharmacologie

7. Department of Internal Medicine and Digestive Diseases, CHU Purpan, UMR 152, IRD Toulouse 3 University

8. Hepatology Unit and INSERM 1183, CHU Montpellier

9. Hepatology Unit, CHU Purpan, Toulouse

10. Institut National de la Santé et de la Recherche Médicale (INSERM), U1065, Team 8, “Hepatic Complications in Obesity,” and University Hospital of Nice, Digestive Centre, Cedex

11. Hepatology Unit, CHU Rennes

12. Hepatology Unit, APHP Paul Brousse, Villejuif

13. Hepatology Unit, Hospices Civils de Lyon, and INSERM U1052, Paris

14. France Recherche Nord & Sud Sida-HIV Hépatites, Paris

15. Hepatology Unit, Hôpital Saint Joseph, Marseille

16. National Reference Center for Viral Hepatitis B, C, and D, Department of Virology, Hôpital Henri Mondor, Université Paris-Est, and INSERM U955, Créteil, France

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/66/7/1013/24398141/cix916.pdf

Reference14 articles.

1. Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens;Pawlotsky;Gastroenterology,2016

2. NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: prevalence and effect on treatment outcome;Zeuzem;J Hepatol,2017

3. EASL recommendations on treatment of hepatitis C 2016;European Association for the Study of the Liver;J Hepatol,2017

4. C-SWIFT retreatment (part B): 12 weeks of elbasvir/grazoprevir with sofosbuvir and ribavirin successfully treated GT1-infected subjects who failed short-duration all-oral therapy;Lawitz;Hepatology,2015

5. Simeprevir (SMV) plus daclatasvir (DCV) and sofosbuvir (SOF) in treatment-naive and -experienced patients with chronic hepatitis C virus genotype 1 or 4 infection and decompensated liver disease: interim results from the phase II IMPACT study;Lawitz;J Hepatol,2015

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C Virus Antiviral Drug Resistance and Salvage Therapy Outcomes Across Australia;Open Forum Infectious Diseases;2024-03-18

2. HLA-E*01:01 allele is associated with better response to anti-HCV therapy while homozygous status for HLA-E*01:03 allele increases the resistance to anti-HCV treatments in frequently transfused thalassemia patients;Human Immunology;2022-07

3. The Role of RASs /RVs in the Current Management of HCV;Viruses;2021-10-18

4. A Retrospective Cohort Study: Safety and Effectiveness of Elbasvir/Grazoprevir ± Ribavirin Compared With Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir ± Ribavirin in Patients With Chronic Hepatitis C Genotype 1 Infection;Frontiers in Pharmacology;2021-09-09

5. Liver Transplantation and HCV Genotype 4;Advances in Hepatology;2021-07-28